COLIN RABACH: Open Payments
NPI 1699444687 · MONTAGUE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,284 in 61 payments from 15 companies in 2025. Trend: 2023 $898 · 2024 $948 · 2025 $1,284
Food & beverage: $1,284
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $282 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $190 |
| Novo Nordisk Inc | 7 | $150 |
| PFIZER INC. | 7 | $120 |
| Lundbeck LLC | 3 | $90 |
| Exact Sciences Corporation | 4 | $80 |
| ABBVIE INC. | 4 | $77 |
| Amgen Inc. | 4 | $77 |
| Eisai Inc. | 1 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
Products named: CAPLYTA, FARXIGA, AIRSUPRA, REXULTI, OTEZLA, ELIQUIS, Saxenda, The Cologuard Plus Collection Kit.
Industry payments across MI — which companies pay providers there.
